| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $282M | — | — | — | — |
| Op. Income | $56M | — | — | — | — |
| Gross Margin | 36.5% | — | — | — | — |
| Net Margin | 18.3% | — | — | — | — |
| EPS (Diluted) | $0.17 | — | — | — | — |
| Free Cash Flow | $95M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $282M |
| Cost of Revenue | $179M |
| GROSS PROFIT | $103M |
| R&D Expenses | $9M |
| Selling & Marketing | $8M |
| General & Administrative | $28M |
| SG&A Expenses | $36M |
| Other Expenses | $2M |
| Operating Expenses | $48M |
| Cost & Expenses | $227M |
| OPERATING INCOME | $56M |
| Interest Income | $10M |
| Interest Expense | $4M |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $61M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $52M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $52M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $52M |
| D&A | $7M |
| EBIT | $61M |
| EBITDA | $68M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $282M |
| Cost of Revenue | $179M |
| GROSS PROFIT | $103M |
| R&D Expenses | $9M |
| Selling & Marketing | $8M |
| General & Administrative | $28M |
| SG&A Expenses | $36M |
| Other Expenses | $2M |
| Operating Expenses | $48M |
| Cost & Expenses | $227M |
| OPERATING INCOME | $56M |
| Interest Income | $10M |
| Interest Expense | $4M |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $61M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $52M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $52M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $52M |
| D&A | $7M |
| EBIT | $61M |
| EBITDA | $68M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $52M |
| Depreciation & Amortization | $7M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $126M |
| Change in Working Capital | -$90M |
| OPERATING CASH FLOW | $95M |
| Capital Expenditure | -$220.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $30M |
| NET CASH FROM INVESTING | $30M |
| Net Debt Issuance | -$370.0K |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $4M |
| NET CASH FROM FINANCING | $4M |
| FREE CASH FLOW | $95M |
| Net Change in Cash | $128M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $604M |
| Short-Term Investments | $95M |
| Net Receivables | $576M |
| Inventory | $0 |
| Other Current Assets | $31M |
| TOTAL CURRENT ASSETS | $1.3B |
| PP&E (Net) | $7M |
| Goodwill | $0 |
| Intangible Assets | $72M |
| Long-Term Investments | $0 |
| Tax Assets | $5M |
| Other Non-Current Assets | $17M |
| TOTAL NON-CURRENT ASSETS | $102M |
| TOTAL ASSETS | $1.4B |
| Account Payables | $817M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $65M |
| TOTAL CURRENT LIABILITIES | $898M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $4M |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $6M |
| TOTAL LIABILITIES | $904M |
| Common Stock | $588.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $479M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $25M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $505M |
| Minority Interest | $134.0K |
| TOTAL EQUITY | $505M |
| TOTAL LIABILITIES & EQUITY | $1.4B |
| Total Debt | $4M |
| Net Debt | -$601M |
